A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)

Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
12/2006
12/26/2006	US7153859 For prophylaxis and therapy of asthma, chronic obstructive pulmonary disease, chronic bronchitis, atopic dermatitis, urticaria, allergic rhinitis, allergic conjunctivitis, vernal conjunctivitis, eosinophilia, psoriasis, rheumatoid arthritis, septic shock, ulcerative colitis, Crohn's disease
12/26/2006	US7153857 antiinflammatory agents; antiarthritic agents; anticancer agents
12/26/2006	US7153856 Orally administering N-(2-chloro-6-methylphenyl)-2-[4-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-6-ylamino]thiazole-5-carboxamide for treating cancer
12/26/2006	US7153852 Skin disorders; antiinflammatory agents; brain disorders; chronic obstructive pulmonary disease; antiarthritic agents; inflammatory bowel disorders
12/26/2006	US7153834 A homogeneous cyclosporin solution comprising a carrier dialkyl ester of aliphatic or aromatic dioic acid, hydrophilic lipophilic balance, forming emulsions in stomach with gastrointestinal fluids
12/26/2006	US7153833 Therapeutic uses of SMR1 peptides
12/26/2006	US7153678 Polynucleotides encoding the novel human phosphatase, RET31, and variants thereof
12/26/2006	US7153669 Nucleotide sequences coding protein for use in the diagnosis, treatment and prevention of autoimmune, cell proliferative and inflammatory diseases
12/26/2006	US7153662 Inflammation-specific peptides and the uses thereof
12/26/2006	US7153507 A human monoclonal antibody specifically binds to human IL-15 and to inhibit IL-15-induced proinflammatory effects; tumor necrosis factor; antiinflammatory, -arthritic, -carcinogenic, proliferative agents; rheumatic diseases; transplants
12/21/2006	WO2006135828A2 Trisubstituted amines as phosphodiesterase 4 inhibitors
12/21/2006	WO2006135109A1 Method for treatment of proliferative disease utilizing inhibition of formation of synoviolin homooligomer
12/21/2006	WO2006134955A1 1, 2-di(cyclic group)substituted benzene derivative
12/21/2006	WO2006134877A1 Injection
12/21/2006	WO2006134384A1 Anti-inflammatory agents
12/21/2006	WO2006134146A1 Orthopaedic skeletal demonstration aids
12/21/2006	WO2006133941A2 Cannabinoid active pharmaceutical ingredient for improved dosage forms
12/21/2006	WO2006122242A3 Compositions and methods for the treatment of inflammatory bowel disease utilizing nf-kb decoy polynucleotides
12/21/2006	WO2006097293A3 Combination of a steroid sulfatase inhibitor and an ascomycin
12/21/2006	WO2006089005A3 Combination of selective factor viia and/or xia and plasma kallikrein inhibitors
12/21/2006	WO2006084145A3 Methods of using il-1 antagonists to reduce c-reactive protein
12/21/2006	WO2005105097A3 Pyridopyrimidines for treating inflammatory and other diseases
12/21/2006	US20060287536 Phenyl-thiophene type vitamin d receptor modulators
12/21/2006	US20060287502 C3b/C4b complement receptor-like molecules and uses thereof
12/21/2006	US20060287377 Vanilloid receptor 1 (VR 1) antagonists; efficacy; N-(3-Fluoro-4-methoxy-phenyl)-2-(7-nitro-1H-benzimidazol-1-yl)-acetamide,
12/21/2006	US20060287374 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
12/21/2006	US20060287361 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof as opoid receptors ligands
12/21/2006	US20060287354 Azaindole compounds as kinase inhibitors
12/21/2006	US20060287339 Aza- and polyazanthranyl amides and their use as medicaments
12/21/2006	US20060287338 Metalloproteinase inhibitor compounds
12/21/2006	US20060287284 Pharmaceutical composition combining tenatoprazole and an anti-inflamatory agent
12/21/2006	US20060287223 Remodeling and glycoconjugation of peptides
12/21/2006	US20060286556 Autoimmune encephalomyelitis; multiple sclerosis; antagonize or inhibit CXCL13
12/21/2006	US20060286150 Prevent menopause syndrome; therapy for skin aging; topical applying
12/21/2006	US20060286125 Immunomodulation; Yatapoxvirus polypeptide; multiple sclerosis, psoriasis, atopic dermatitis, type 1 insulin-dependent diabetes mellitus, dermatitis, Sjoigren's syndrome, encephalitis, Reiter's syndrome, psoriatic arthritis, progressive systemic sclerosis, primary biliary cirrhosis
12/21/2006	US20060286043 Delivery of antihistamines through an inhalation route
12/21/2006	US20060286042 Condensation aerosol for delivery of a drug selected from the group consisting of zaleplon, zolpidem and zopiclone
12/21/2006	DE102005018026B4 Substituierte Styrole, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer Substituted styrenes, processes for their preparation and their use as anti-inflammatories
12/21/2006	CA2612298A1 Anti-inflammatory agents
12/21/2006	CA2612217A1 Anti-inflammatory agents
12/21/2006	CA2612061A1 Stable cannabinoid compositions comprising crystalline trans-(±)-delta9-tetrahydrocannibinol
12/21/2006	CA2611917A1 Injection
12/21/2006	CA2611562A1 Trisubstituted amines as phosphodiesterase 4 inhibitors
12/21/2006	CA2607054A1 1, 2-di(cyclic group)substituted benzene derivative
12/21/2006	CA2596412A1 Anti-connexin compounds and uses thereof
12/21/2006	CA2578844A1 Semi-soft c-class immunostimulatory oligonucleotides
12/20/2006	EP1734133A2 Heparanase specific molecular probes and their use in research and medical applications
12/20/2006	EP1734119A2 CD16-II variants
12/20/2006	EP1734116A2 Thrombin derivatives and medicinal composition containing the same
12/20/2006	EP1733740A1 Therapeutic agent for auris interna disorder containing il-6 antagonist as active ingredient
12/20/2006	EP1733738A1 Method of preventing ultraviolet ray-induced apoptosis
12/20/2006	EP1733726A1 Pharmaceutically active isoindoline derivatives
12/20/2006	EP1733724A1 Amino alcohol compound
12/20/2006	EP1733721A2 Use of astaxanthin or esters thereof as a phosphodiesterase inhibitor
12/20/2006	EP1733237A2 Diagnostics and therapeutics for diseases associated with peroxisome proliferative activated receptor alpha (ppara)
12/20/2006	EP1732905A1 2-aminomethylthiazole-5-carboxamides as protein kinase modulators
12/20/2006	EP1732900A2 Acrylonitrile derivatives for inflammation and immune-related uses
12/20/2006	EP1732896A1 Substituted pyridones as inhibitors of poly(adp-ribose) polymerase (parp)
12/20/2006	EP1732892A1 Tetrahydrocarbazoles and derivatives
12/20/2006	EP1732561A1 Combination of cb2 modulators and pde4 inhibitors for use in medicine
12/20/2006	EP1732560A1 Substituted cinnolin-4-ylamines
12/20/2006	EP1732559A2 Methods of treatment using eszopiclone
12/20/2006	EP1732558A1 1-[2h-1-benzopyran-2-one-8-yl]- piperazine derivatives for the treatment of pain
12/20/2006	EP1732555A1 Opioid delivery system
12/20/2006	EP1732552A2 2,6-disubstituted piperidines as modulators of chemokine receptor activity
12/20/2006	EP1732543A2 Tetra-cyclic carboline deratives for inhibiting angiogenesis
12/20/2006	EP1732531A2 Amines and amides for the treatment of diseases
12/20/2006	EP1622610B1 1-(2h-pyrazol-3-yl)-3-{4-[1-(benzoyl)-piperidin-4-ylmethyl]-phenyl}-urea derivatives and related compounds as inhibitors of p38 kinase and/or tnf inhibitors for the treatment of inflammations
12/20/2006	EP1542977B1 2,5-dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase mmp12.
12/20/2006	EP1441726B1 Derivatives of phenoxy-n-'4-(isothiazolidin-1,1-dioxid-2yl)pheny]-valerian- acid amide and other compounds as inhibitors of the coagulation factor xa in the treatment of thromboembolic diseases and tumors
12/20/2006	EP1438310B1 Beta-carbolin derivatives as ptp-inhibitors
12/20/2006	EP1434762B1 4'-methanesulfonyl-biphenyl derivatives as a highly selective cyclooxygenase-2 inhibitor
12/20/2006	EP1390362B1 Substituted benzofurans and benzothiophenes, methods of making and methods of use as integrin antagonists
12/20/2006	EP1276488B1 Use of lactic acid bacterium for the prevention of peritonitis
12/20/2006	EP1256344B1 Remedies for endothelin-induced diseases
12/20/2006	EP1187816B1 5-cyano-2-aminopyrimidine derivatives
12/20/2006	EP1135477B1 Humanized monoclonal integrin antibodies
12/20/2006	EP1131294B1 Quinoline derivatives as nk-2 and nk-3 receptor ligands
12/20/2006	CN2848220Y Fever downing refreshment plaster
12/20/2006	CN1882610A High-yield method for the production of human antibodies blocking the biological activity of a human cytokine
12/20/2006	CN1882587A Use of tricyclic compounds as glycine transport inhibitors
12/20/2006	CN1882585A Hydroxyalkyl substituted pyrido-7-pyrimidin-7-ones
12/20/2006	CN1882562A Benzofurans and benzothiophenes
12/20/2006	CN1882542A 2-pyridone derivatives as neutrophil elastase inhibitors and their use
12/20/2006	CN1882375A Treatment of amyloid- and epileptogenesis-associated diseases
12/20/2006	CN1882350A Method for controlling angiogenesis in animals
12/20/2006	CN1882349A Aqueous solution preparation containing aminoglycoside antibiotic and bromfenac
12/20/2006	CN1880328A Preparation method of hyperin and hypericin of Hypericum perforatum
12/20/2006	CN1880319A Tropane derivatives as CCR5 modulators
12/20/2006	CN1880306A Substituted indeno[1,2-c]isoquinoline derivatives and methods of use thereof
12/20/2006	CN1880301A Tiopronin lysine and its preparing process and use
12/20/2006	CN1880294A Polymorphic forms of dexketoprofen trometamol, preparation and pharmaceutical compositions thereof
12/20/2006	CN1879882A Combine injection formulation
12/20/2006	CN1879881A Yeast vaccine production method
12/20/2006	CN1879868A Medicine for treating dysmenorrhea and its preparing method
12/20/2006	CN1879867A Formulation and its preparation process
12/20/2006	CN1879856A An externally applied ointment
12/20/2006	CN1879840A A nano 'Xing Nao Jing' injection and method for preparing same
12/20/2006	CN1879835A A swelling-reducing pain-easing ointment and method for preparing same
12/20/2006	CN1879833A An wind-expelling ointment and method for preparing same

1 ... 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 ... 1272